A Novel Inhibitor of Poly( ADP - R ibose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line via the DNA D amage– A ctivated cGAS–STING Pathway
Chemical Research in Toxicology · 2024
DOI: 10.1021/acs.chemrestox.3c00343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Yonglong Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao 266000, China. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: China Scholarship Council, Qilu Special Project of Clinical Research Fund of Shandong Medical Association, Shandong traditional Chinese medicine science and technology development plan project.
Abstract (Originalsprache)
Loss-of-function mutations in the Breast Cancer Susceptibility Gene (BRCA1 and BRCA2) are often detected in patients with breast cancer. Poly(ADP-ribose) polymerase-1 (PARP1) plays a key role in the repair of DNA strand breaks, and PARP inhibitors have been shown to induce highly selective killing of BRCA1/2-deficient tumor cells, a mechanism termed synthetic lethality. In our previous study, a novel PARP1 inhibitor─(E)-2-(2,3-dibromo-4,5-dimethoxybenzylidene)-N-(4-fluorophenyl) hydrazine-1-carbothioamide (4F-DDC)─was synthesized, which significantly inhibited PARP1 activity with an IC50 value of 82 ± 9 nM. The current study aimed to explore the mechanism(s) underlying the antitumor activity of 4F-DDC under in vivo and in vitro conditions. 4F-DDC was found to selectively inhibit the proliferation of BRCA mutant cells, with highly potent effects on HCC-1937 (BRCA1-/-) cells. Furthermore, 4F-DDC was found to induce apoptosis and G2/M cell cycle arrest in HCC-1937 cells. Interestingly, immunofluorescence and Western blot results showed that 4F-DDC induced DNA double strand breaks and further activated the cGAS-STING pathway in HCC-1937 cells. In vivo analysis results revealed that 4F-DDC inhibited the growth of HCC-1937-derived tumor xenografts, possibly via the induction of DNA damage and activation of the cGAS-STING pathway. In summary, the current study provides a new perspective on the antitumor mechanism of PARP inhibitors and showcases the therapeutic potential of 4F-DDC in the treatment of breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiotherapy, The Affiliated Hospital of Qingdao University, Qingdao 266000, China.
- School of Public Health, Qingdao University, Qingdao 266071, China.
- Department of Molecular Craniofacial Embryology and Oral Histology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Bunkyo-ku, Tokyo 113-8510, Japan.
- Department of Oral, Plastic and Aesthetic Surgery, Hospital of Stomatology, Jilin University, Changchun, Jilin 130021, China.
- Department of Radiotherapy, Yizhou Tumor Hospital, Zhuozhou 072750, China.
- Department of Radiotherapy, University of Tsukuba Hospital, Tsukuba 305-8576, Japan.
ORCID-Profile: Chuanlong Guo
Förderung
- China Scholarship Council
- Qilu Special Project of Clinical Research Fund of Shandong Medical Association
- Shandong traditional Chinese medicine science and technology development plan project
Zitieren
APA
Jin, Y., Wang, L., Jin, C., Zhang, N., Shimizu, S., Xiao, W., Guo, C., Liu, X., & Si, H. (2024). A Novel Inhibitor of Poly( ADP - R ibose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line via the DNA D amage– A ctivated cGAS–STING Pathway. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.3c00343
Vancouver
Jin Y, Wang L, Jin C, Zhang N, Shimizu S, Xiao W, et al. A Novel Inhibitor of Poly( ADP - R ibose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line via the DNA D amage– A ctivated cGAS–STING Pathway. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.3c00343
BibTeX
@article{Jin2024,
author = {Jin, Yonglong and Wang, Lijie and Jin, Chengxue and Zhang, Na and Shimizu, Shosei and Xiao, Wenjing and Guo, Chuanlong and Liu, Xiguang and Si, Hongzong},
title = {A Novel Inhibitor of Poly( ADP - R ibose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line via the DNA D amage– A ctivated cGAS–STING Pathway},
journal = {Chemical Research in Toxicology},
year = {2024},
doi = {10.1021/acs.chemrestox.3c00343}
}
EUVIMED